Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153127 · ClinicalTrials.gov registry record · Phase 4
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
A Phase 4 study of Constipation, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT00153127 is a Phase 4 study of Constipation that has completed, run by Braintree Laboratories. The registered enrollment target is 100 participants, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00153127, a Phase 4 study of Constipation, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.
Conditions Studied
Interventions
- DRUG polyethyleneglycol3350
Study Locations (4)
Alabama
- - Mobile
Florida
- - St. Petersburg
Missouri
- - St Louis
North Carolina
- - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00153127
The ClinicalTrials.gov registry entry for NCT00153127 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (51% lower). The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which polyethyleneglycol3350 is the first listed.
NCT00153127 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Florida, Missouri.
Frequently Asked Questions
What is clinical trial NCT00153127 about?
NCT00153127 is a clinical study titled "Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications". The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.
What is the current status of trial NCT00153127?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-11.
What conditions does trial NCT00153127 study?
This clinical trial studies the following conditions: Constipation.
What interventions are being tested in trial NCT00153127?
The interventions under investigation include: polyethyleneglycol3350 (DRUG).
Who is sponsoring clinical trial NCT00153127?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00153127 being conducted?
This trial has 4 study locations across Alabama, Florida, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
RECRUITING · Phase 4
-
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen
RECRUITING · Phase 4
-
Preop Laxatives in Robotic Urologic Surgery
RECRUITING · Phase 4
-
Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients
COMPLETED · Phase 4
-
An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients
COMPLETED · Phase 4
-
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.